Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06997185 · ClinicalTrials.gov registry record · NA
Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs
A NA study of Cancer, sponsored by London School of Economics and Political Science.
- Recruiting
- Registry status
- NA
- Development phase
- 3,000
- Enrollment target
- 1
- Study location
NCT06997185: Recruiting NA study of Cancer, sponsored by London School of Economics and Political Science.
NCT06997185 is a NA study of Cancer that is actively recruiting participants, run by London School of Economics and Political Science. The registered enrollment target is 3,000 participants, below the 3,486-participant average among 615 other Cancer trials with a reported enrollment target (14% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06997185, a NA study of Cancer, is actively recruiting participants, sponsored by London School of Economics and Political Science.
- RECRUITING
- Registry status
- NA
- Development phase
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This nationally representative randomized survey of US adults will evaluate the effect of using brief statements to communicate different sources of uncertainty about the benefits and harms of new cancer drugs on participants' decisions and understanding.
Conditions Studied
Interventions
- OTHER Statement communicating uncertainty with a single arm trial
- OTHER Statement communicating uncertainty with limited study duration
- OTHER Statement communicating uncertainty with a limited study population
- OTHER Statement communicating uncertainty with an unvalidated surrogate endpoint
- OTHER Statement communicating uncertainty with treatment effect size
Study Locations (1)
Massachusetts
- Harvard Medical School and Harvard Pilgrim Health Care Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2025-05-09 |
| Est. Completion | 2025-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06997185
The ClinicalTrials.gov registry entry for NCT06997185 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,486-participant average among 615 other Cancer trials with a reported enrollment target (14% lower). The listed sponsor is London School of Economics and Political Science, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 5 interventions - of which Statement communicating uncertainty with a single arm trial is the first listed.
NCT06997185 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06997185 about?
NCT06997185 is a clinical study titled "Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs". This nationally representative randomized survey of US adults will evaluate the effect of using brief statements to communicate different sources of uncertainty about the benefits and harms of new cancer drugs on participants' decisions and understanding.
What is the current status of trial NCT06997185?
This trial is currently recruiting. It is a NA study. The enrollment target is 3,000 participants. The study started on 2025-05-09. Estimated completion is 2025-06.
What conditions does trial NCT06997185 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT06997185?
The interventions under investigation include: Statement communicating uncertainty with a single arm trial (OTHER), Statement communicating uncertainty with limited study duration (OTHER), Statement communicating uncertainty with a limited study population (OTHER), Statement communicating uncertainty with an unvalidated surrogate endpoint (OTHER), Statement communicating uncertainty with treatment effect size (OTHER).
Who is sponsoring clinical trial NCT06997185?
This trial is sponsored by London School of Economics and Political Science, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06997185 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.